Similar articles

• Verification bias and the prostate-specific antigen test--is there a case for a lower threshold for biopsy?

  Schröder FH, Kranse R. Schröder FH, et al. N Engl J Med. 2003 Jul 24;349(4):393-5. doi: 10.1056/NEJMe030073. N Engl J Med. 2003. PMID: 12878747 No abstract available.
• Verification bias in screening for prostate cancer.

  Chatterton HT. Chatterton HT. N Engl J Med. 2003 Oct 23;349(17):1672-3; author reply 1672-3. N Engl J Med. 2003. PMID: 14575055 No abstract available.
• Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen.

  Punglia RS, D'Amico AV, Catalona WJ, Roehl KA, Kuntz KM. Punglia RS, et al. N Engl J Med. 2003 Jul 24;349(4):335-42. doi: 10.1056/NEJMoa021659. N Engl J Med. 2003. PMID: 12878740
• [Present-day possibilities of prostate cancer screening in patients with benign prostatic hyperplasia before and after surgical treatment].

  Pushkar' DIu, Rasner PI, Skobelev PP. Pushkar' DIu, et al. Urologiia. 2001 Nov-Dec;(6):48-54. Urologiia. 2001. PMID: 11785083 Review. Russian. No abstract available.
• Advances in the application of prostate-specific antigen in the detection of early-stage prostate cancer.

  Kamoi K, Babaian RJ. Kamoi K, et al. Semin Oncol. 1999 Apr;26(2):140-9. Semin Oncol. 1999. PMID: 10597725 Review.